Evidence map›Paper›PMID 28323460›Full record

ArticleAmerican journal of public health2017

Supply-Side Disruption in Cocaine Production Associated With Cocaine-Related Maternal and Child Health Outcomes in the United States.

Chris Delcher, Melvin Livingston, Yanning Wang, Meredith Mowitz, Mildred Maldonado-Molina, Bruce A Goldberger

Open access · greenAbstract read
In one paragraph

Article in American journal of public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chris DelcherChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
Melvin LivingstonChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
Yanning WangChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
Meredith MowitzChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
Mildred Maldonado-MolinaChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
Bruce A GoldbergerChris Delcher, Yanning Wang, and Mildred Maldonado-Molina are with the Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville. Melvin Livingston is with the Department of Biostatistics and Epidemiology, University of North Texas, Fort Worth. Meredith Mowitz is with the Department of Pediatrics, College of Medicine, University of Florida. Bruce A. Goldberger is with the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida.
University of North Texas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the effects of precursor chemical regulation aimed at reducing cocaine production on cocaine-related maternal and newborn hospital stays in the United States.

methodsWe analyzed monthly counts of maternal and neonatal stays from January 2002 through December 2013 by using a quasi-experimental interrupted time series design. We estimated the preregulation linear trend, postregulation change in linear trend, and abrupt change in level.

resultsThe number of monthly cocaine-related maternal and neonatal stays decreased by 221 and 128 stays, respectively, following the cocaine precursor regulation change. We also observed a further decline in per-month maternal and neonatal stays of 18 and 8 stays, respectively.

conclusionsA supply-side disruption in the United States cocaine market was associated with reduced hospital stays for 2 vulnerable populations: pregnant women and newborns. Results support findings that federal precursor regulation can positively reduce cocaine availability in the United States.

Indexed as

AdultChild HealthCocaineCocaine-Related DisordersFemaleHumansInfant, NewbornLength of StayPregnancyPregnancy ComplicationsUnited StatesCocaine

Identifiers

PMID28323460
PMCPMC5388966
OpenAlexW2598665850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.